The Immune System – News and Features

News
Co-Located Cell Types Help Drive Aggressive Brain Tumors
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, a new study has found.

News
Weakness in Lung Cancer’s Defenses Identified
Researchers have identified how a genetic flaw in some lung cancers alters cancer cell metabolism to fuel the disease.

News
Mechanism That Regulates Immune Responses to Parasites Identified for the First Time
Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites.

News
Gene Modification Could Improve Immune Cells’ Ability To Combat Cancer
A new study reveals that modifying the CUL5 gene enhances CAR-T cell therapy for leukemia and lymphoma. This improves cell longevity and tumor-fighting power, reducing cancer relapse.

News
Antiviral Bat Gene Discovery Could Lead to New Approaches To Fight Viruses
The discovery of antiviral genes in bats that protect them from pathogens could lead to new approaches to combat viral diseases.

Article
Addressing Widening Health Disparities With Inclusive Stem Cell Models
Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse stem cell lines for disease research could improve global health equity.

News
Immune Mapping of Pancreatic Cancer Offers Insights for Precision-Targeted Treatment
Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

Article
Organoids, Beyond the Hype
The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of these models, ultimately increasing drug testing accuracy and revolutionizing biomedical science.

News
Cystic Fibrosis Alters the Immune System From Childhood
A study led by TUM researchers finds that cystic fibrosis alters immune cells early in life, likely before birth. These immature immune cells fail to fight infections, fueling persistent inflammation and lung damage.

News
“All-Tablet” Treatment Shows Promise for Common Form of Leukemia
An international study of over 800 chronic lymphocytic leukemia (CLL) patients found that an all-tablet therapy of acalabrutinib-venetoclax – with or without obinutuzumab –improved progression-free survival compared to chemotherapy.
Advertisement